Most Recent Additions*
The impact of SPOP gene alterations in men with metastatic prostate cancer: Results from the Prostate Cancer Precision Medicine Multi-Institutional Collaborative Effort (PROMISE) consortium
Kyra L. Yamamoto, Nicholas Henderson, Clara Hwang, Pedro C. Barata, Mehmet A. Bilen, Deepak Kilari, Laura Graham, Rohan Garje, Shoshana Rothstein, Vadim S. Koshkin, Abhishek Tripathi, Frank C. Cackowski, Jones T. Nauseef, Michael T. Schweizer, Andrew J. Armstrong, Tanya B. Dorff, Ajjai S. Alva, and Rana R. McKay
A phase I/II study of antroquinonol in combination with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer
Yan-Shen Shan, Chung-Pin Li, Gazala Khan, Woo Jin Lee, Hye Jin Choi, Heung-Moon Chang, Moon Hee Lee, John M. Wallmark, and Pei-Ni Chen
A Phase I/II Study of GDA-201, Cryopreserved Nicotinamide-Enhanced Allogeneic Natural Killer Cells, in Patients with Relapsed/Refractory B-Cell Lymphoma
Brian C. Shaffer, Matthew J. Frigault, Muhamad Alhaj Moustafa, Edward Peres, Stephanie B. Tsai, Stuart Levy, Yona Geffen, Roei Mazor, and Veronika Bachanova
Diversity of patients enrolled in SWOG gastrointestinal cancers therapeutic trials
Rachael A. Safyan, Sarah Colby, Colmar Figueroa-Moseley, Katherine A. Guthrie, E. Gabriela Chiorean, and Philip A. Philip
SWOG S2303: Randomized phase II/III trial of 2nd line nivolumab + paclitaxel + ramucirumab versus paclitaxel + ramucirumab in patients with PD-L1 CPS 1 advanced gastric and esophageal adenocarcinoma (PARAMUNE)
Anwaar Saeed, Sarah Colby, Paul Eliezer Oberstein, Dan G. Duda, Rajiv Agarwal, Colmar Figueroa-Moseley, Riha Vaidya, Joseph M. Unger, Katherine A. Guthrie, Flavio G. Rocha, Maheswari Senthil, Rachael A. Safyan, Zev A. Wainberg, Syma Iqbal, E. Gabriela Chiorean, and Philip A. Philip
Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT)
Nitin Ohri, Shruti Jolly, Benjamin T. Cooper, Rafi Kabarriti, William R. Bodner, Jonathan Klein, Chandan Guha, Shankar Viswanathan, Elaine Shum, Joshua K. Sabari, Haiying Cheng, Rasim A. Gucalp, Enrico Castellucci, Angel Qin, Shirish M. Gadgeel, and Balazs Halmos
NRG-GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-NORTH AMERICA)
Christopher Hanyoung Lieu, Guan Yu, Scott Kopetz, Shannon L. Puhalla, Peter C. Lucas, Ibrahim Halil Sahin, Dustin A. Deming, Philip A. Philip, Theodore S. Hong, Yesenia Rojas-Khalil, Jonathan M. Loree, Norman Wolmark, Greg Yothers, Thomas J. George, and Arvind Dasari
Abatacept with FluBu2: To Use or Not to Use
Luis F. Gonzalez-Mosquera, Klodiana Neme, Nancy Mikulandric, Izabela Mazur, Josephine Emole, Asif Alavi, Edward Peres, Muneer H. Abidi, and Shatha Farhan
HEALTHCARE-ASSOCIATED INFECTIONS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A NATIONWIDE ANALYSIS
John Cuenca, Bernard Moscoso, Diana Cardenas, Marissa Schettino, Daniel Gonzalez-Mosquera, Pool Tobar, Luis Gonzalez-Mosquera, and Joseph Nates
RGI-2001 with CNI-Based Prophylaxis Demonstrates Better Acute Gvhd-Free Survival Following Myeloablative Allohct without Increased Relapse: Comparison of a Multi-Center Phase 2b Study with a Contemporaneous CIBMTR Cohort
Yi-Bin Chen, Shatha Farhan, Lazaros J. Lekakis, Gary J. Schiller, Jean A. Yared, Markus Y. Mapara, Amer Assal, Hannah Choe, Zachariah DeFilipp, Dana D. Lee, Hayley Lane, Linda J. Burns, Mei-Jie Zhang, Matthew Bye, Ted A. Gooley, and Ayman Saad
A phase I/II study of antroquinonol in combination with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer
Yan-Shen Shan, Chung-Pin Li, Gazala Khan, Woo Jin Lee, Hye Jin Choi, Heung-Moon Chang, Moon Hee Lee, John M. Wallmark, and Pei-Ni Chen
A phase 2 clinical trial of first-in-class fascin inhibitor NP-G2-044 as monotherapy and in combination therapy with anti-PD-1 immunotherapy in patients with advanced solid tumor malignancies
Frank Yung-Chin Tsai, Michael J. Birrer, Jason R. Brown, Sanjay Chandrasekaran, Vincent Chung, Richard C. Frank, Edward G. Garmey, Shirish M. Gadgeel, Thomas J. George, Shadia I. Jalal, Andrew S. Poklepovic, Jennifer M. Segar, Alexander I. Spira, Jue J. Zhang, and Anup Kasi
Ipatasertib in patients with AKT1/2/3 mutation-positive (AKTmut) tumors: TAPISTRY study
David Thomas, Gennaro Daniele, Jeong Eun Kim, Shirish M. Gadgeel, Eugene R. Ahn, Luis G. Paz-Ares, Hans Prenen, David Chen, Junhan Fang, Timothy R. Wilson, Brian Simmons, and Fabrice Barlesi
Beyond the initial diagnosis: Epidemiological factors associated with second primary cancers among patients with head and neck squamous cell carcinoma (a SEER-based study)
Anand Shah, Pranav Gwalani, Rajvi Gor, Dhairya Gor, Abiram Sivanandam, and Anupama H. Nehra
Evaluation and treatment response in patients with hormone receptor-positive, HER2 low metastatic breast cancer: A single center retrospective analysis
Muhammad A. Shahid, Radhika B. Kulkarni, Linda Albusoul, Brigid Jacob, Courtney M. Rose, Kylie Springer, and Vrushali S. Dabak
Evaluation of cytokine release syndrome (CRS) in patients with relapsed or refractory multiple myeloma (RRMM) receiving step-up priming doses and longer dosing intervals of elranatamab: MagnetisMM-9
Douglas W. Sborov, Charlotte Pawlyn, Tadao Ishida, Jeffrey S. Y. Huang, Reuben Benjamin, Shinsuke Iida, Rakesh Popat, Junya Kuroda, Matthew J. Pianko, Aravind Ramakrishnan, Steven R. Schuster, Vrushali S. Dabak, Alexander M. Lesokhin, Umberto Conte, Pooneh Soltantabar, Fangxin Hong, Erik Vandendries, and Rafael Fonseca
Real-world outcomes in patients with biomarker-selected early-stage non-small cell lung cancer
Fawzi Abu Rous, Jesse Sussell, Celina Ngiam, Qing Zhang, Thomas Majda, Daniel Sheinson, Sarika Ogale, Ilze Bara, Katja Schulze, and Shirish M. Gadgeel
Race and decisional conflict about genetic testing in patients with advanced prostate cancer
James P. Purtell, Avery Ralston, Courtney M. Rose, Kyle McElyea, Farhan Ibrahim, Alexandra Thompson, Sunita Ghosh, and Clara Hwang
Interim analysis of ABM-1310, a blood-brain barrier-penetrant BRAF inhibitor, in patients with BRAF V600-mutated solid tumors
Sarina A. Piha-Paul, Macarena Ines De La Fuente, Fabio Iwamoto, Seema Nagpal, Amy M. Weise, Jay-Jiguang Zhu, Sunandana Chandra, Chen Chen, Yali Fu, Zandong Yang, and Katy K. Tsai
Patient-reported and clinical outcomes among patients with pancreatic cancer
Rayli Pichardo, Brigid Jacob, Maria Jamil, Dawood Jamil, Shahm Raslan, Courtney M. Rose, Eric Adjei Boakye, Laila Poisson, Samantha Tam, and Philip A. Philip
*Updated as of 12/21/24.
